Author

Sawa Yamashiro

Observed name: Yamashiro, Sawa

Institution: Rohto Pharmaceutical (Japan)

Observed institutions: Rohto Pharmaceutical (Japan), Institute for Protein Research, The University of Osaka, The University of Osaka

ORCID: 0000-0001-8889-6398

Observed ORCID: 0000-0001-8889-6398

OpenAlex ID: A5021792467

A Text-Based Computational Framework for Patient-Specific Modeling for Classification of Cancers

2021 · Hiroaki Imoto, Sawa Yamashiro, et al. · iScience · 22

Building patient‐specific models for receptor tyrosine kinase signaling networks

2021 · Kyoichi Ebata, Sawa Yamashiro, et al. · FEBS Journal · 11

The heterogeneity of dermal mesenchymal cells reproduced in skin equivalents regulates barrier function and elasticity

2026 · Shun Kimura, Sachiko Sekiya, et al. · EMBO Reports · 1

Protocol for stratification of triple-negative breast cancer patients using in silico signaling dynamics

2022 · Hiroaki Imoto, Sawa Yamashiro, et al. · STAR Protocols · 1

Author Reply to Peer Reviews of The heterogeneity of dermal mesenchymal cells reproduced in skin equivalents regulates barrier function and elasticity

2025 · Shun Kimura, Sachiko Sekiya, et al.

Regulation of cell cycle by EGF receptor family

2019 · Sawa Yamashiro, Hiroaki Imoto, et al. · The Molecular Biology Society of Japan

Works count: 7

Citation count: 36

H-index: 2

I10-index: 2